 |
PDBsum entry 1t9e
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1t9e
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
44:1145-1153
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1.
|
|
M.L.Korsinczky,
R.J.Clark,
D.J.Craik.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
SFTI-1 is a novel 14 amino acid peptide comprised of a circular backbone
constrained by three proline residues, a hydrogen-bond network, and a single
disulfide bond. It is the smallest and most potent known Bowman-Birk trypsin
inhibitor and the only one with a cyclic peptidic backbone. The solution
structure of [ABA(3,11)]SFTI-1, a disulfide-deficient analogue of SFTI-1, has
been determined by (1)H NMR spectroscopy. The lowest energy structures of native
SFTI-1 and [ABA(3,11)]SFTI-1 are similar and superimpose with a root-mean-square
deviation over the backbone and heavy atoms of 0.26 +/- 0.09 and 1.10 +/- 0.22
A, respectively. The disulfide bridge in SFTI-1 was found to be a minor
determinant for the overall structure, but its removal resulted in a slightly
weakened hydrogen-bonding network. To further investigate the role of the
disulfide bridge, NMR chemical shifts for the backbone H(alpha) protons of two
disulfide-deficient linear analogues of SFTI-1, [ABA(3,11)]SFTI-1[6,5] and
[ABA(3,11)]SFTI-1[1,14] were measured. These correspond to analogues of the
cleavage product of SFTI-1 and a putative biosynthetic precursor, respectively.
In contrast with the cyclic peptide, it was found that the disulfide bridge is
essential for maintaining the structure of these open-chain analogues. Overall,
the hydrogen-bond network appears to be a crucial determinant of the structure
of SFTI-1 analogues.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Łegowska,
A.Lesner,
E.Bulak,
A.Jaśkiewicz,
A.Sieradzan,
M.Cydzik,
P.Stefanowicz,
Z.Szewczuk,
and
K.Rolka
(2010).
Inhibitory activity of double-sequence analogues of trypsin inhibitor SFTI-1 from sunflower seeds: an example of peptide splicing.
|
| |
FEBS J,
277,
2351-2359.
|
 |
|
|
|
|
 |
J.Austin,
R.H.Kimura,
Y.H.Woo,
and
J.A.Camarero
(2010).
In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1.
|
| |
Amino Acids,
38,
1313-1322.
|
 |
|
|
|
|
 |
J.E.Swedberg,
S.J.de Veer,
and
J.M.Harris
(2010).
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
|
| |
Biol Chem,
391,
357-374.
|
 |
|
|
|
|
 |
L.Cascales,
and
D.J.Craik
(2010).
Naturally occurring circular proteins: distribution, biosynthesis and evolution.
|
| |
Org Biomol Chem,
8,
5035-5047.
|
 |
|
|
|
|
 |
R.J.Clark,
and
D.J.Craik
(2010).
Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
|
| |
Biopolymers,
94,
414-422.
|
 |
|
|
|
|
 |
K.Brzozowski,
R.Majewski,
A.Jaśkiewicz,
A.Legowska,
L.Klaudel,
S.Rodziewicz-Motowidło,
and
K.Rolka
(2008).
Conformational studies of [Abu(3, 11)]-SFTI-1, an analogue of the trypsin inhibitor isolated from sunflower seeds.
|
| |
J Pept Sci,
14,
911-916.
|
 |
|
|
|
|
 |
N.L.Daly,
Y.K.Chen,
F.M.Foley,
P.S.Bansal,
R.Bharathi,
R.J.Clark,
C.P.Sommerhoff,
and
D.J.Craik
(2006).
The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold.
|
| |
J Biol Chem,
281,
23668-23675.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |